Lyons T

Centre for Psychedelic Research, Imperial College London, London, UK.

15 papers · 3 preprints · ORCID

ArticlePsilocybin

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.

Pasquini L, Vohryzek J, Escrichs A +12

Europe PMC2026
ArticlePsilocybin

Human brain changes after first psilocybin use.

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2026
ArticlePsilocybin

Effects of psychedelic use on authoritarian attitudes revisited.

Simonsson O, Lyons T, Marks J +5

Europe PMC2026
ArticlePsychedelics

Validation of the Imperial Psychedelic Predictor Scale - CORRIGENDUM.

Angyus M, Osborn S, Haijen E +5

Europe PMC2025
ArticlePsilocybin

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.

Henry J, Giribaldi B, Nutt DJ +3

Europe PMC2025
ArticlePsilocybin

Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.

Roseby W, Kettner H, Roseman L +7

Europe PMC2025
PreprintPsilocybin

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial

Henry J, Giribaldi B, Nutt DJ +3

Europe PMC2025
ArticlePsilocybin

From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).

Zeifman RJ, Spriggs MJ, Kettner H +5

Europe PMC2025
ArticlePsilocybin

An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.

Godfrey K, Weiss B, Zhang X +5

Europe PMC2025
PreprintPsilocybin

Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits

Pasquini L, Vohryzek J, Escrichs A +12

Europe PMC2024
PreprintPsilocybin

Human brain changes after first psilocybin use

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2024
ArticlePsychedelics

Validation of the imperial psychedelic predictor scale.

Angyus M, Osborn S, Haijen E +5

Europe PMC2024
ArticleMDMA

A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project.

Syrjanen R, Schumann JL, Lyons T +7

Europe PMC2023
ArticlePsychedelics

Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging.

Buchborn T, Lyons T, Song C +2

Europe PMC2023
ArticlePsilocybin

Body mass index (BMI) does not predict responses to psilocybin.

Spriggs MJ, Giribaldi B, Lyons T +9

Europe PMC2023
ArticlePsychedelics

Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Peill JM, Trinci KE, Kettner H +6

Europe PMC2022
ArticlePsychedelics

The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner.

Buchborn T, Lyons T, Song C +2

Europe PMC2020
ArticlePsilocybin

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.

Lyons T, Carhart-Harris RL

Europe PMC2018